← Browse by Condition
Medical Condition

suicide and self harm

Total Trials
3
Recruiting Now
3
Trial Phases
Various

ClinicalMetric tracks all active clinical trials for suicide and self harm sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — suicide and self harm Clinical Trials

How many clinical trials are currently recruiting for suicide and self harm?
ClinicalMetric currently tracks 3 actively recruiting clinical trials for suicide and self harm, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 3. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for suicide and self harm?
suicide and self harm research spans multiple clinical trial phases. Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a suicide and self harm clinical trial?
Eligibility criteria for suicide and self harm trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Top Sponsors
Haukeland University Hospital 1 trial
Butler Hospital 1 trial
Central South University 1 trial

Recruiting Clinical Trials

NCT06315075
Recruiting
Dialectical Behavior Therapy for Adolescents With Self-harm and Suicidal Behavior- an Open Trial
Enrollment
140 pts
Location
Norway
Sponsor
Haukeland University Hospital
View Trial →
NCT05180344
Recruiting
Feasibility, Acceptability, and Preliminary Efficacy of a Novel Personalized Mobile Intervention for Suicide - Open Trial (2)
Enrollment
10 pts
Location
United States
Sponsor
Butler Hospital
View Trial →
NCT06210100
Recruiting
aiTBS for NSSI and Suicide in Adolescent Depression
Enrollment
60 pts
Location
China
Sponsor
Central South University
View Trial →

Related Conditions

suicidal ideation (3) self harm (1) suicide (1) suicide attempted (1) non suicidal self injury (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology